Interreg project granted!

This conference features discussion of target and compound discovery, new potential antituberculosis compounds in development, clinical trial design and early trial results, and alternative approaches to tuberculosis treatment.

Dr. David Barros, TB Drug Discovery Director at GSK DDW, has been appointed Vice-chairman and Chairman for the 2013 and 2015 Conferences, respectively. More information on the Conference's website.